- Global Pharma News & Resources

STATEMENT: Civica Rx Supports Biden Administration Recommendations for Strengthening the Pharmaceutical Supply Chain

LEHI, Utah--(BUSINESS WIRE)--Civica Rx (Civica, Inc.) welcomes the findings of the 100-day supply chain review. The report identifies key vulnerabilities in the generic drug supply chain that contribute to drug shortages and supply risks during a global public health emergency. Among the next steps outlined in the report, we particularly applaud the intent to bolster domestic manufacturing capacity for key products, ensure that reimbursement and procurement policy supports supply chain resilience, and to develop quality maturity ratings that will allow purchasers to recognize quality along with price in procurement decisions.

About Civica Rx

Civica Rx is a 501(c)(4) social welfare organization established in 2018 by health systems (CommonSpirit Health, HCA Healthcare, Intermountain Healthcare, Mayo Clinic, Providence St. Joseph Health, SSM Health, and Trinity Health) and philanthropies (Gary and Mary West Foundation, Laura and John Arnold Foundation, and Peterson Center on Healthcare) to reduce chronic generic drug shortages and related price spikes in the United States. Celebrating its 2nd Anniversary in 2020, Civica is making strides to ensure patients and their needs come first and that essential generic medications are accessible and affordable.

Civica Rx by the Numbers

  • Civica serves over 50 health systems, representing more than 1,400 hospitals and approximately one-third of all licensed hospital beds in the United States (Civica also supplies the U.S. Department of Veterans Affairs, the U.S. Department of Defense and “340B” hospitals, which care for vulnerable patients in some of the most underserved areas of the country).
  • To date, Civica has provided over 40 million vials or syringes of essential generic medications to hospitals, which have been used to treat over 15 million patients.
  • Eleven Civica medications have been used to help care for COVID-19 patients, including neuromuscular blocking agents, sedatives, pain management medications, and blood thinners.
  • Civica and its supply partners met surge hospital demand of up to 400 percent for some medications and also provided 2.1 million vials to the U.S. Strategic National Stockpile.
  • Civica now over 50 different generic medications available for hospitals in multiple dosage forms and is building towards 100 drugs by 2023.

Learn more at or on LinkedIn.


Allan Coukell, Government Affairs
+1 (617) 999-9193

Debbi Ford, Communications
+1 (970) 227-3991

Editor Details

  • Company:
    • Businesswire
Last Updated: 08-Jun-2021